drugset / Trial / NCT06456489

Pulse Steroid Injection in Refractory Rheumatoid Arthritis

NCT06456489

Phase 3 Unknown 268 enrolled Sohag University
RandomizedParallel-groupSingle-blindTreatment

Summary

Remission or low disease activity in active rheumatoid arthritis

Timeline

Start
2024-05-01
Primary completion
2024-09-30
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 125 mg Intravenous

Indications